Richard Gregory
Director/Board Member chez CANBRIDGE PHARMACEUTICALS INC.
Fortune : 10 224 $ au 31/03/2024
Profil
Richard James Gregory is an Independent Non-Executive Director at CANbridge Pharmaceuticals Inc. He previously held positions as an Independent Director at ProMIS Neurosciences, Inc. from 2016 to 2023, Chief Scientific Officer & Director at Canbridge Pharmaceuticals, Inc. (United States), Independent Director at Homology Medicines, Inc., Chief Scientific Officer & Executive VP-Research at ImmunoGen, Inc. from 2015 to 2019, and Head-Research & Development at Genzyme Corp.
from 2011 to 2014.
Dr. Gregory obtained a doctorate degree from the University of Massachusetts in 1986 and an undergraduate degree from Virginia Polytechnic Institute & State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01% | 17/04/2023 | 600 ( 0,01% ) | 10 224 $ | 31/03/2024 |
| 05/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Richard Gregory
| Sociétés | Poste | Début |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Director/Board Member | 21/04/2020 |
Anciens postes connus de Richard Gregory
| Sociétés | Poste | Fin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Director/Board Member | 27/04/2023 |
| IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | 30/08/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Chief Tech/Sci/R&D Officer | - |
| Q32 BIO INC. | Director/Board Member | - |
Formation de Richard Gregory
| University of Massachusetts | Doctorate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
